Enveric Biosciences, Inc. (ENVB) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ENVB Revenue Growth
ENVB Revenue Analysis (2013–2024)
As of May 8, 2026, Enveric Biosciences, Inc. (ENVB) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, ENVB's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $48.6 million in 2017.
When compared to Healthcare sector peers including ATAI (+811.8% YoY), and LSCC (+17.4% YoY). Compare ENVB vs ATAI →
ENVB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ENVBCurrent | $0 | - | - | - | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 LSCC | $523M | +17.4% | +5.1% | 2.9% |
ENVB Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-337,489 | - | $-9,632,266 | - |
| 2023 | $0 | - | $-408,030 | - | $-16,448,440 | - |
| 2022 | $0 | - | $-435,201 | - | $-19,961,444 | - |
| 2021 | $0 | - | $-681,612 | - | $-25,944,502 | - |
| 2020 | $0 | -100.0% | $-120,872 | - | $-5,617,317 | - |
| 2019 | $39.9M | -7.2% | $8.2M | 20.4% | $-6,324,894 | -15.8% |
| 2018 | $43.0M | -11.5% | $9.0M | 20.9% | $-7,146,460 | -16.6% |
| 2017 | $48.6M | +34.4% | $10.2M | 21.1% | $-11,970,689 | -24.6% |
| 2016 | $36.1M | +126.2% | $6.5M | 18.1% | $-5,379,863 | -14.9% |
| 2015 | $16.0M | - | $5.8M | 36.0% | $-1,870,665 | -11.7% |
See ENVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ENVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ENVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonENVB — Frequently Asked Questions
Quick answers to the most common questions about buying ENVB stock.
Is ENVB's revenue growth accelerating or slowing?
ENVB TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ENVB's long-term revenue growth rate?
Enveric Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ENVB's revenue distributed by segment?
ENVB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.